Literature DB >> 9569364

Effect of carbon dioxide pneumoperitoneum on bacteremia and severity of peritonitis in an experimental model.

T Ipek1, M Paksoy, T Colak, E Polat, N Uygun.   

Abstract

BACKGROUND: Laparoscopy is increasingly used in conditions complicated by peritonitis. A theoretical concern is that carbon dioxide pneumoperitoneum may increase bacteremia.
METHOD: In 60 rats peritonitis was induced by cecostomy. Animals were randomly allocated to pneumoperitoneum (PP) and control groups. Blood cultures and intraabdominal swabs were assessed. A peritonitis severity score (PSS) was computed based on histology from peritoneal biopsy.
RESULTS: One hour after cecostomy neither in abdominal swabs nor in blood samples bacteria were reproduced in PP and control groups. Three hours after cecostomy the frequency of positive blood cultures was 80% and 20% in PP and control groups, respectively (p < 0.0001). Six hours after cecostomy the frequency of positive blood cultures was 100% in each group (p > 0.05). One hour after cecostomy the mean peritoneal severity score was significantly higher in the PP group than in the control group, but there was not any significant difference between groups 3 and 6 h after cecostomy. The mean peritoneal severity scores were found to be significantly increased with time when the PP groups compared with each other.
CONCLUSION: In rats, pneumoperitoneum can't cause a more severe peritonitis but it does induce an increase in the rate of bacteremia within the early 6-h period of peritonitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569364     DOI: 10.1007/s004649900697

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  8 in total

1.  Totally laparoscopic repair of an ileal and uterine iatrogenic perforation secondary to endometrial curettage.

Authors:  Rosario Vecchio; Salvatore Marchese; Vito Leanza; Antonio Leanza; Eva Intagliata
Journal:  Int Surg       Date:  2015-02

2.  Effect of a pneumoperitoneum on systemic cytokine levels, bacterial translocation, and organ complications in a rat model of severe acute pancreatitis with infected necrosis.

Authors:  O Strobel; D Wachter; J Werner; W Uhl; C A Müller; M Khalik; H K Geiss; W Fiehn; M W Büchler; C N Gutt
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

3.  Inflammatory response and bacterial dissemination after laparotomy and abdominal CO2 insufflation in a murine model of peritonitis.

Authors:  M B Pitombo; O H Lupi; R N Gomes; R Amâncio; R A Refinetti; P T Bozza; H C Castro-Faria-Neto
Journal:  Surg Endosc       Date:  2006-05-15       Impact factor: 4.584

4.  Lavage by laparoscopy fares better than lavage by laparotomy: experimental evidence.

Authors:  L Linhares; H Jeanpierre; F Borie; A Fingerhut; B Millat
Journal:  Surg Endosc       Date:  2001-01       Impact factor: 4.584

5.  EFFECTS OF TOPICAL TREATMENT WITH EUPHORBIA TIRUCALLI LATEX ON THE SURVIVAL AND INTESTINAL ADHESIONS IN RATS WITH EXPERIMENTAL PERITONITIS.

Authors:  Lilhian Alves de Araújo; Fátima Mrué; Roberpaulo Anacleto Neves; Maxley Martins Alves; Nelson Jorge da Silva-Júnior; Marcelo Seixo de Brito Silva; Paulo Roberto de Melo-Reis
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

6.  Effects of pneumoperitoneum created through CO2 insufflation and parameters of mechanical ventilation (PEEP application) on systemic dissemination of intraabdominal infections.

Authors:  U Barbaros; S Ozarmagan; Y Erbil; A Bozbora; N Cakar; H Eraksoy; Y Kapran; B Kiran
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

7.  Increased transperitoneal bacterial translocation in laparoscopic surgery.

Authors:  M C Horattas; N Haller; D Ricchiuti; D Ricchiutti
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

8.  The effects of pneumoperitoneum and controlled ventilation on peritoneal lymphatic bacterial clearance: experimental results in rats.

Authors:  Armando Angelo Casaroli; Lycia M J Mimica; Belchor Fontes; Samir Rasslan
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.